Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder in premenopausal women, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Patients frequently present comorbidities, including obesity, insulin resistance, and impaired glucose and...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež, Mojca Jensterle
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-10-01
Sarja:	Life
Aiheet:	polycystic ovary syndrome prolactin metabolic homeostasis cardiometabolic markers dopamine agonist
Linkit:	https://www.mdpi.com/2075-1729/13/11/2124
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!